Sofinnova Investments, Inc. has filed its 13F form on August 09, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.8 Billion distributed in 82 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $168M, Vera Therapeutics, Inc. with a value of $101M, Ascendis Pharma A/S with a value of $100M, Novo Nordisk A S with a value of $92.7M, and Edwards Lifesciences Corp with a value of $66.9M.

Examining the 13F form we can see an increase of $84.9M in the current position value, from $1.72B to 1.8B.

Sofinnova Investments, Inc. is based out at Menlo Park, CA

Below you can find more details about Sofinnova Investments, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $1.8 Billion
Healthcare: $1.58 Billion
ETFs: $215 Million
Basic Materials: $2.99 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 82
  • Current Value $1.8 Billion
  • Prior Value $1.72 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 09, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 17 stocks
  • Additional Purchases 32 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.